Holen Sie sich die Stockscreener-App
44.01
0.69%
-0.3058
Handel nachbörslich:
44.03
0.0212
+0.05%
Schlusskurs vom Vortag:
$44.31
Offen:
$44.5
24-Stunden-Volumen:
10,676
Relative Volume:
1.36
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.87%
1M Leistung:
-6.94%
6M Leistung:
+2.23%
1J Leistung:
+42.33%
1-Tages-Spanne:
$43.95
$44.83
1-Wochen-Bereich:
$43.95
$46.89
52-Wochen-Spanne:
$30.32
$51.42
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
44.01 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
362.36 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
738.65 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
741.91 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
281.43 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
705.88 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
(GNOM) Risk Channels and Responsive Allocation - Stock Traders Daily
Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Global X Rare Earth & Critical Materials ETF (EART) Short Interest & Short Float | Updated May 2026 - MarketBeat
Beyond tech industry: Here's how biotech ETFs are riding the AI wave - MSN
(GNOM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Global X Fds Genomics & Biotechnology Etf | NPORT-P: Others - Moomoo
Liquidity Mapping Around (GNOM) Price Events - Stock Traders Daily
Stock List: Research Stocks from Around the World - GuruFocus
GNOMZ ETF Holdings List — AQUISUK:GNOMZ - TradingView
GNOMZ ETF Analysis: Dividends, Returns AQUISUK:GNOMZ - TradingView
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks
Why (GNOM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Global X Genomics & Biotechnology ETF (GNOM) stock price, news, quote and history - Yahoo Finance UK
Understanding Momentum Shifts in (GNOM) - Stock Traders Daily
GNOMZ Stock Fund Price and Chart — AQUISUK:GNOMZ - TradingView
IBBQ, GNOM, BIB: Biotech ETFs Offer Exposure to Healthcare Startup Companies - TipRanks
The Next Big Theme: March 2026 - Global X ETFs
Biotech Stocks and Longevity Investing: Trends To Track - Newsweek
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - AOL.com
Biotech stocks and longevity investing: Trends to track - AOL.com
Avoiding Lag: Real-Time Signals in (GNOM) Movement - Stock Traders Daily
Global X Genomics & Biotechnology ETF Index OverviewStock Price, Quote and News - marketscreener.com
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
GNOM Technical Analysis & Stock Price Forecast - Intellectia AI
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - The Globe and Mail
Global X Genomics & Biotechnology ETF: Performance & Quotes, GNOM.EU Stock Price on Nasdaq Exchange - MarketScreener
Discipline and Rules-Based Execution in GNOM Response - news.stocktradersdaily.com
GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks
GNOM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
Behavioral Patterns of GNOM and Institutional Flows - Stock Traders Daily
EDGAR Filing Documents for 0001135428-20-000018 - SEC.gov
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026 - TipRanks
How to Buy Moderna Stock (MRNA) in 2026 - The Motley Fool
The Next Big Theme: February 2026 - Global X ETFs
The long game: ASX ETFs to target amidst an ageing population - MSN
(GNOM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
5 Small-cap Biotech ETFs to Watch - Nasdaq
Entravision Communications (NYSE:EVC) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Lakeland Financial (NASDAQ:LKFN) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
German American Bancorp (NASDAQ:GABC) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
AlTi Global (NASDAQ:ALTI) Shares Pass Above Two Hundred Day Moving Average – What’s Next? - Defense World
Demand Brands (OTCMKTS:DMAN) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Mercury General (NYSE:MCY) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Riverview Bancorp (NASDAQ:RVSB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
VirnetX (NYSE:VHC) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
IBBQ, GNOM, BIB: Gain Exposure to Healthcare Startups with Biotech ETFs - TipRanks
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):